INSMED Inc - Common Stock, par value $0.01 per share (INSM)

Historical Holders from Q1 2014 to Q3 2025

Symbol
INSM on Nasdaq
CUSIP
457669307
Type / Class
Equity / Common Stock, par value $0.01 per share
Shares outstanding
211M
All holders as of September 30, 2025
Q3 2025
Total 13F shares, excl. options
211M
Holdings value
$30.3B
% of all portfolios
0.036%
Grand Portfolio weight change
+0.001%
Number of holders
546
Number of buys
307
Number of sells
-262
Average Value change %
-0.01%
Average buys %
+0.004%
Average sells %
-0.014%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of INSMED Inc - Common Stock, par value $0.01 per share (INSM)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
JPMORGAN CHASE & CO 10.8% +36.3% $2.98B $1.02B 23M +51.8% JPMORGAN CHASE & CO. Aug 29, 2025
Darwin Global Management, Ltd. 9.7% +13.3% $2.95B $729M 20.5M +32.9% Darwin Global Management, Ltd. Sep 30, 2025
VANGUARD GROUP INC 10.18% $1.25B 18.2M The Vanguard Group Dec 31, 2024
BlackRock, Inc. 5.1% $639M 9.73M BlackRock, Inc. Jun 30, 2025
PRICE T ROWE ASSOCIATES INC /MD/ 3.3% -43.3% $998M -$619M 6.93M -38.3% T. Rowe Price Associates, Inc. Sep 30, 2025

Institutional Holders of INSMED Inc - Common Stock, par value $0.01 per share (INSM)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 211M $30.3B +$449M $144.01 546
2025 Q2 210M $21.1B +$1.36B $100.64 511
2025 Q1 198M $15.1B +$439M $76.29 434
2024 Q4 193M $13.3B +$360M $69.04 433
2024 Q3 186M $13.6B +$788M $73.00 417
2024 Q2 175M $11.7B +$1.88B $67.00 386
2024 Q1 148M $4.02B -$32M $27.13 292
2023 Q4 761K $23.6M -$1.87M $30.99 4
2023 Q3 146M $3.69B +$65.8M $25.25 245
2023 Q2 145M $3.06B +$10.5M $21.10 217
2023 Q1 145M $2.47B +$36.8M $17.05 225
2022 Q4 143M $2.86B +$305M $19.98 220
2022 Q3 122M $2.63B -$229M $21.54 222
2022 Q2 125M $2.46B +$53M $19.72 192
2022 Q1 125M $2.93B +$71.2M $23.50 203
2021 Q4 123M $3.34B -$21.8M $27.24 197
2021 Q3 123M $3.39B +$40M $27.54 184
2021 Q2 121M $3.45B +$433M $28.46 192
2021 Q1 106M $3.62B -$7.46M $34.06 191
2020 Q4 107M $3.58B -$45.4M $33.29 199
2020 Q3 109M $3.49B -$56.3M $32.14 192
2020 Q2 111M $3.04B +$367M $27.54 179
2020 Q1 96.9M $1.55B -$33.1M $16.03 154
2019 Q4 98.3M $2.35B -$38.9M $23.88 168
2019 Q3 98.3M $1.73B -$529M $17.64 149
2019 Q2 126M $3.23B +$1.16B $25.60 161
2019 Q1 82.1M $2.39B -$5.04M $29.07 147
2018 Q4 82.3M $1.08B -$9.3M $13.12 118
2018 Q3 80.9M $1.64B -$43.3M $20.22 119
2018 Q2 82.4M $1.95B +$34.2M $23.65 123
2018 Q1 81.8M $1.84B +$128M $22.52 124
2017 Q4 75.9M $2.37B +$46.2M $31.18 123
2017 Q3 73.7M $2.29B +$541M $31.21 139
2017 Q2 55.5M $952M +$47.9M $17.16 106
2017 Q1 56.9M $996M +$70.3M $17.51 94
2016 Q4 57.8M $765M +$2.35M $13.23 95
2016 Q3 57.5M $834M +$19.2M $14.52 93
2016 Q2 56.5M $557M -$8.09M $9.86 103
2016 Q1 57M $722M -$12.9M $12.67 95
2015 Q4 56.6M $1.03B +$272K $18.15 109
2015 Q3 56.8M $1.05B +$35.4M $18.57 117
2015 Q2 53.5M $1.31B +$18.2M $24.42 113
2015 Q1 51.6M $1.07B +$253M $20.80 114
2014 Q4 41.6M $644M +$12.7M $15.47 91
2014 Q3 41.3M $539M +$116M $13.05 99
2014 Q2 29.7M $593M -$7.58K $19.98 101
2014 Q1 29.2M $555M +$49.2M $19.04 106